BIOTIE THERAPIES CORP. Stock Price - BITI

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Biotie Therapies Corp. (MM) BITI NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 25.80 0.00 0.00 0.00 25.80 20:00:00
Bid Price Ask Price Spread Spread % News
25.81 33.57 7.76 23.12% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

BIOTIE THERAPIES CORP. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 316.35M 12.26M $ -28.32M -3.47 - 12.26M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

BIOTIE THERAPIES CORP. News

Loading Messages....

Latest BITI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical BITI Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

BIOTIE THERAPIES CORP. Description

Biotie Therapies Corp is a Finland based biopharmaceutical company engaged in developing and marketing therapies that restore function and improve the lives of people with neurological disorders in Finland and the United States. Its product portfolio includes CVT-301, CVT-427, SYN120, rHIgM22 and BTT1023. CVT-301 is a potential therapy for Parkinson's disease, Advance CVT-427 is a potential acute treatment for a migraine, SYN120 is a therapeutic option for people with Parkinson's disease dementia; and Advance clinical development of rHIgM22, a remyelinating antibody, as a potential treatment for people with MS. Its brand includes AMPYRA and Qutenza.


Your Recent History
NASDAQ
BITI
BIOTIE THE..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.